Skip to main content
. 2006 Jan 23;3(1):99–107. doi: 10.1093/ecam/nek013

Figure 2.

Figure 2

Histogram showing changes in PCV of subjects fed either placebo or drug (Ars alb-30) of 1 month treatment group against negative control; statistical significance levels calculated by considering differences between data of subjects of Group I and subjects of Group II, before administration of either placebo (BP) or verum (BD-30); aP < 0.05; bP < 0.01; cP < 0.001.